Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma

Background Response to chemotherapy is a prognostic factor in patients with Ewing sarcoma (ES); the role of FDG PET to predict response in these patients has not been thoroughly investigated. We evaluated the diagnostic accuracy and the potential of FDG PET to predict response to chemotherapy (CHT)....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical & translational oncology 2016-02, Vol.18 (2), p.189-195
Hauptverfasser:	Raciborska, A., Bilska, K., Drabko, K., Michalak, E., Chaber, R., Pogorzała, M., Połczyńska, K., Sobol, G., Wieczorek, M., Muszyńska-Rosłan, K., Rychlowska-Pruszyńska, M., Rodriguez-Galindo, C., Dziuk, M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bone Neoplasms - diagnostic imaging Bone Neoplasms - drug therapy Bone Neoplasms - pathology Child Child, Preschool Disease Progression Female Fluorodeoxyglucose F18 Humans Kaplan-Meier Estimate Male Medicine Medicine & Public Health Multimodal Imaging Oncology Positron-Emission Tomography - methods Prognosis Proportional Hazards Models Radiopharmaceuticals Research Article Retrospective Studies Sarcoma, Ewing - diagnostic imaging Sarcoma, Ewing - drug therapy Sarcoma, Ewing - pathology Tomography, X-Ray Computed Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!